Search results
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 4 hours agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why
Zacks via Yahoo Finance· 4 months agoInovio Pharma (INO) surges 134% in a month, mainly due to its plans to submit a regulatory...
INOVIA's (INO) Rare Disease Drug Gets EC's Orphan Tag, Stock Up
Zacks via Yahoo Finance· 12 months agoINOVIA (INO) shares surge 12% in the after-market hours, when its drug for treating a rare...
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 months agoThe consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical...
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 months agoImage source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q4 2023 Earnings Call Mar 06,...
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
Motley Fool via Yahoo Finance· 2 weeks agoSome investors might remember Inovio Pharmaceuticals (NASDAQ: INO); others might not. The small-cap...
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's...
Zacks via Yahoo Finance· 2 years agoInovio (INO) doesn't possess the right combination of the two key ingredients for a likely earnings...
Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors...
Simply Wall St. via Yahoo Finance· 1 year agoInovio Pharmaceuticals, Inc. (NASDAQ:INO) shareholders should be happy to see the share price up 11%...
Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 year agoInovio (INO) delivered earnings and revenue surprises of -31.25% and 72.59%, respectively, for the...
Stock Market Plunge: 2 Stocks to Avoid Right Now
Motley Fool· 2 years agoIt's more important than ever to make highly selective investment decisions with a struggling stock market, challenging economic issues, and dangerous...